Association between Helicobacter pylori and Barrett%26apos;s Esophagus: A Case-Control Study

作者：Fischbach Lori A^*; Graham David Y; Kramer Jennifer R; Rugge Massimo; Verstovsek Gordana; Parente Paola; Alsarraj Abeer; Fitzgerald Stephanie; Shaib Yasser; Abraham Neena S; Kolpachi Anna; Gupta Swapna; Vela Marcelo F; Velez Maria; Cole Rhonda; Anand Bhupinderjit; El Serag Hashem B

来源：American Journal of Gastroenterology, 2014, 109(3): 357-368.

DOI：10.1038/ajg.2013.443

OBJECTIVES: The estimated association between Helicobacter pylori and Barrett%26apos;s esophagus (BE) has been heterogenous across previous studies. In this study, we aimed to examine the association between H. pylori and BE and to identify factors that may explain or modify this association. %26lt;br%26gt;METHODS: We conducted a case-control study in which we used screening colonoscopy controls recruited from primary care clinics as our primary control group in order to minimize selection bias. All participants underwent an esophagogastroduodenoscopy with gastric mapping biopsies. We used logistic regression to obtain odds ratios (ORs) and 95% confidence intervals (CIs) to estimate the association between H. pylori and BE while controlling for confounders. %26lt;br%26gt;RESULTS: We identified 218 cases and 439 controls. The overall OR for the association between H. pylori and BE after controlling for age and white race was 0.55 (95% CI: 0.35-0.84). We observed an even stronger inverse association (OR: 0.28; 95% CI: 0.15, 0.50) among participants with corpus atrophy or antisecretory drug use %26gt;= 1 time per week (factors thought to lower gastric acidity), and no inverse association in patients without these factors (OR: 1.32; 95% CI: 0.66, 2.63). %26lt;br%26gt;CONCLUSIONS: The association between H. pylori and a decreased risk for BE appears to occur in patients with factors that would likely lower gastric acidity (corpus atrophy or taking antisecretory drugs at least once a week).

• 出版日期2014-3